Key result
Milrinone is linked to ~70% lower inpatient mortality in pediatric isolated diastolic left heart failure.
Why the study?
Data on diastolic heart failure in pediatric patients are scarce and often derived from adult trials or theoretic and anecdotal evidence.
Are specific pharmacologic and mechanical interventions associated with inpatient mortality and length of stay in critically ill pediatric patients with isolated diastolic left heart failure?
Observational (n=2,273)
Yes
Are specific pharmacologic and mechanical interventions associated with inpatient mortality and length of stay in critically ill pediatric patients with isolated diastolic left heart failure?
Answers are grounded in this paper and cite their sources.
In critically ill pediatric patients with isolated diastolic left heart failure, milrinone and angiotensin converting enzyme inhibitors are associated with decreased inpatient mortality.
Background : Diastolic heart failure may be noted in pediatric patients with congenital heart disease, cardiomyopathy, or malignancies requiring chemotherapy, but the available data are scarce, and often derived from adult trials or based on theoretic or anecdotal evidence. Methods: Data between 2016 and 2021 were obtained from Pediatric Health Information System database. Patients < 18 years of age with isolated diastolic heart failure admitted to intensive care unit at some point during admission were included. They were divided into patients with and without inpatient mortality. Patients’ demographics, comorbidities using ICD-10 codes, and pharmacologic interventions were also recorded. Univariate analysis was done in demographics, comorbidities, pharmacologic interventions, and mechanical interventions between admissions with and without mortality. Multivariable logistic regression was done for inpatient mortality and multivariable linear regression was done for total hospital length of stay in survivors. Results: Isolated diastolic heart failure comprised 0.5% of critically ill pediatric patients. 121 (5%) experienced mortality among the 2,273 admissions in the final analyses. Milrinone and angiotensin converting enzyme inhibitor were found to be associated with decreased mortality. Increasing age and diuretics were associated with decreased total hospital length of stay in survivors. Conclusion: Pediatric critical care admissions with isolated diastolic left heart failure have a 5% mortality. Several comorbidities and interventions are associated with increased mortality with milrinone and angiotensin converting enzyme inhibitors being associated with decreased risk of mortality. When only admissions with survival to discharge are considered, older age and diuretics are associated with lower total hospital length of stay.
No takes yet. Share an insight, caveat, or question.
Loomba et al. (2022) conducted an observational in Isolated diastolic left heart failure (n=2,273). Milrinone vs. No milrinone was evaluated on Inpatient mortality (OR 0.3, 95% CI 0.1 to 0.6, p=<0.01). In critically ill pediatric patients with isolated diastolic left heart failure, milrinone use was associated with a 70% reduction in the odds of inpatient mortality.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: